Protein-ligand binding affinity prediction using SARS-CoV-2

The urgency of the COVID-19 pandemic has accelerated drug discovery efforts, prompting advancements in computational methods. This study aims to predict protein-ligand (PL) binding affinities using atomic-resolution structural data from SARS-CoV-2 interactions with ligands. Utilizing data from large-scale ensemble-docking experiments, Multivariate Linear Regression (MLR) and Random Forest (RF) regression models were trained. Despite marginal improvement with RF, both models struggled to establish reliable predictions, highlighting the complexity of PL binding affinity prediction. Future work entails exploring larger RF models, integrating deep learning approaches, and developing novel predictor features for enhanced predictive capabilities.

Protein-ligand binding affinity prediction using SARS-CoV-2

Files

Links to Files

Permanent Link

Collections

Author/Creator

Author/Creator ORCID

Date

Type of Work

Department

Program

Citation of Original Publication

Rights

Subjects

Abstract